Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer (Q58086861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

title

Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Mei Gao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Miranda Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Richard A Moffitt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Marcela A Salazar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Jeffrey Vacirca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Chuan Huang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Kenneth R Shroyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Minsig Choi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Georgios V Georgakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Aaron R Sasson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Mark A Talamini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Joseph Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

language of work or name

English

0 references

publication date

31 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

1 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

88-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States

1 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

The blockade of immune checkpoints in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Organoid models of human and mouse ductal pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

CC chemokine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Wnt proteins are lipid-modified and can act as stem cell growth factors

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Inhibitory B7-family molecules in the tumour microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Prognostic value of PDL1 expression in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Immune checkpoint therapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy for personalized cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

A simple practice guide for dose conversion between animals and human

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

PD-1 signaling in primary T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Roles for KRAS in pancreatic tumor development and progression

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Targeting the mitogen-activated protein kinase cascade to treat cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Phenotypic screening in cancer drug discovery - past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors.

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

PD-1/PD-L1 inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Companion diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Nivolumab in previously untreated melanoma without BRAF mutation

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Pembrolizumab versus Ipilimumab in Advanced Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

1 reference

https://api.crossref.org/works/10.1038%2FS41416-018-0298-0

7 January 2021

The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30377341

12 December 2020

inferred from PubMed ID database lookup

A drug-specific nanocarrier design for efficient anticancer therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30377341

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41416-018-0298-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

PubMed publication ID

30377341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30377341%20AND%20SRC:MED&resulttype=core&format=json